Edwards Lifesciences (EW) PT Lowered to $80 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Edwards Lifesciences (EW) PT Lowered to $80 at Barclays
September 9, 2024 6:54 AM EDTBarclays analyst Matt Miksic lowered the price target on Edwards Lifesciences (NYSE: EW) to $80.00 (from $90.00) while maintaining a Overweight rating.
The analyst comments "What to Do with the Stock Here? We expect increasing interest in EW as we approach TCT (Oct 27-31), given the two key clinical catalysts... More
Edwards Lifesciences (EW) PT Lowered to $80 at Barclays
September 9, 2024 6:54 AM EDTBarclays analyst Matt Miksic lowered the price target on Edwards Lifesciences (NYSE: EW) to $80.00 (from $90.00) while maintaining a Overweight rating.
The analyst comments "What to Do with the Stock Here? We expect increasing interest in EW as we approach TCT (Oct 27-31), given the two key clinical catalysts... More
